hotspot -WSS

hotspot

author：fashion 2025-09-28 08:53:22 - browse：4

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Neuroscience renaissance leads to new crop of psychiatric drugs

WSS

Elisabeth Bik tackles the widespread issue of research misconduct

A timeline of the missing Titanic tourist submersible

Change Healthcare cyberattack shows risk of industry consolidation

Children’s Hospital revives plan for pedestrian bridge

Are embryos people? Reproductive medicine's future depends on the answer

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

entertainment

hotspot

explore

Guidelines to prevent youth baseball injuries need more muscle

5 ways to address the shortage of health care workers

Duchenne breakthrough therapy leaves behind pioneering families

Redefining sustainability for the pharmaceutical industry

ChatGPT in medicine: STAT answers readers' burning questions

Leon Gautier, last member of French D

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Color Health wants to make cancer screenings convenient

Alkermes shareholders re

Elon Musk announces 'temporary limits' for reading Twitter posts

focus

Churchill Downs extends trainer Bob Baffert's ban through 2024

Redefining sustainability for the pharmaceutical industry

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Elisabeth Bik tackles the widespread issue of research misconduct

4 dead, 2 in stable condition in Philadelphia shooting: Police

NASA releases new images of 'fingerprint

entertainment

focus

focus

focus